Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Anika Therapeutics, Inc. is a global joint preservation company focused on early intervention orthopedics, specializing in advancements in orthopedic care [3] - The company leverages expertise in hyaluronic acid and implant solutions to provide minimally invasive products aimed at restoring active living [3] - Anika's operations are headquartered outside of Boston, Massachusetts, and the company targets high opportunity areas within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions [3] Upcoming Event - Dr. Cheryl Blanchard, President and CEO of Anika, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025, at 9:45am PT / 12:45pm ET [1] - Management will also engage in one-on-one investor meetings during the event [1] - The presentation will be available via live webcast and archived for 30 days on Anika's website [2]